Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Dec;268(6):e61-e62.
doi: 10.1097/SLA.0000000000002573.

Optimal Selection of Breast Cancer Patients for Elimination of Surgery Following Neoadjuvant Systemic Therapy

Affiliations
Comment

Optimal Selection of Breast Cancer Patients for Elimination of Surgery Following Neoadjuvant Systemic Therapy

Henry M Kuerer et al. Ann Surg. 2018 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kuerer HM, Rauch GM, Krishnamurthy S, et al. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Ann Surg. 2017 Epub ahead of print. - PMC - PubMed
    1. Heil J, Schaefgen B, Sinn P, et al. Can a pathological complete response of breast cancer after neo-adjuvant chemotherapy be diagnosed by minimal invasive biopsy? Eur J Cancer. 2016;69:142–150. - PubMed
    1. Kuerer H. [Accessed 12 October, 2017];Eliminating Breast Cancer Surgery in Exceptional Responders with Neoadjuvant Systemic Therapy [ClinicalTrials.gov web site] Available at: https://clinicaltrials.gov/ct2/show/NCT02945579.
    1. Kuerer HM, Vrancken Peeters M, Rea DW, et al. Nonoperative management for invasive breast cancer after neoadjuvant systemic therapy: conceptual basis and fundamental international feasibility clinical trials. Ann Surg Oncol. 2017 Epub ahead of print. - PubMed